RxDoctor Payments Data

Juliana Potechin, APRN

Nurse Practitioner · Sanford, NCNPI 1982063947

Payments from drug & device makers

$3,130in general payments, 2019–2025

Across 144 payments — averaging $21.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$913
  • Medtronic$411
  • Abbott$296
  • Scilex Pharmaceuticals Inc.$282
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$180
  • Boston Scientific$135
  • plus $914 from 26 others

What the payments were for

  • Food & beverage$3,130100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,130 in reported general payments places this provider in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$66,523
Medicare patients
218
Services billed
779

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen256$8,047
Lidocaine47$5,607
MovantikNaloxegol Oxalate12$4,809
Buprenorphine31$4,521
Gabapentin325$3,555
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen177$3,040
Pregabalin113$2,293
Tizanidine Hcl153$1,366
Duloxetine Hcl55$627
Methocarbamol48$505
Morphine Sulfate ErMorphine Sulfate29$453
Diclofenac Sodium36$381
Celecoxib34$379
Tramadol Hcl79$310
Oxycodone Hcl13$212

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Redhill Biopharma Inc.Movantik$16$4,80912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Sanford

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →